API consumption patterns are different from production patterns over the globe, as Asia Pacific has the largest market size in producing animal APIs and North America has the highest consumption because of a large number of big pharmaceutical companies present in the region along with a high demand for animal pharmaceuticals in the region. A newly published report by XploreMR titled “Animal Health Active Pharmaceutical Ingredient Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025)” targets the market from the production side and represents the market share of different regions that are into the production of animal APIs. This report is targeted towards the five global regions including North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. By API type, four key segments are considered such as Antiparasitics, Antiinfectives, NSAIDs & Anesthetics and the other APIs such as Anticancer, Gastroenteric, Cardiovascular, and Beta Agonists.
After studying this market in detail, we have considered only the APIs sold to third parties. The therapeutic segment contains drug class that is only mentioned in the definitions section. Scientifically, this segment consists of a large number of therapeutic classes but in the report, they are segmented according to operating business. APIs specifically used for animals are considered in the report instead of APIs used for the manufacturing of both human and animal pharmaceuticals. However, APIs manufactured by any company for its self-consumption is not included because of non-tracking information.
The report focuses on strategies adopted by key players
The key players operating in the global animal health active pharmaceutical ingredient market have adopted various strategies to stand firm in the competitive global market. For instance, Lonza Group AG has focused on strategic agreements and investments in emerging economies, while Ofichem BV has focused on further expansion of the group by collaborating with other organisations and has also invested in facility upgradation. The key focus of Shaanxi Hanjiang Pharmaceutical Group Co., Ltd., is on outsourcing the APIs and cooperative development on API and pharmaceutical intermediates. Strategic cooperation relationships with big international players and focus on anthelmintic veterinary API products is the strategy followed by Changzhou Yabang Qh Pharmachem Co., Ltd.
Global Market Study on Animal Health Active Pharmaceutical Ingredients: Antiparasitics Segment by API Type to Register a CAGR of 7.6% During 2017-2025Buy Now
Custom Market Research Services
xploreMR offers custom market reserch services that help clients to get information on their business scenario required where syndicated solutions are not enough
Why Choose XploreMR
Our analysts go above and beyond to answer your specific queries. We are with you throughout the entire journey – from initial discussion to post-purchase.
Country-wise Analysis & Forecasting
As we track markets at country-level, we are able to offer hard-to-find market intelligence in both developed and emerging countries.
High Quality At Competitive Pricing
We believe high quality market research shouldn’t be out of reach for businesses. Our competitively-priced market research reports ensure businesses of all sizes have access to quality information
A recent market study published by XploreMR offers ibuprofen API market global industry analysis for 2014-2018 and forecast for 2019-2029. The study also offers a comprehensive assessment of ...
Hydrosurgery Systems Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2019 to 2029
Hydrosurgery Systems Market – Report Scope XploreMR recently published a market study on the global market for hydrosurgery systems. The study provides detailed assessment on the key market dyn ...